semaglutide depression anxiety and Depression: What Is the Relationship? Ozempic-like drugs correlated with less

Topics of discussion will include: Monitoring, assessing, and ensuring adequate pharmacovigilance across GLP-1 drugs and manufacturing Flagging and remedying serious adverse effects associated with GLP-1s before facing suit Anticipating and preparing for MDLs and class actions Preempting issues caused by GLP-1 usage Afternoon Networking Break Phyllis Hurwitz MarcusVice President, National Advertising DivisionBBB National Programs Maria RisingInfluencerTirzepatide Tales & The Rising Project Claire DaviesShareholderPolsinelli From television to TikTok, from busses to subways, from podcasts to newspapers, it is impossible to escape GLP-1 advertisements in 2026

The most common side effects of GLP-1 medications include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distention, hypoglycemia in patients with type II diabetes

Why dual agonists face unique challenges Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it has structural features for binding two different receptor types

it works by stimulating two hormone receptors in your body instead of just one, as semaglutide does

This is particularly concerning if you monitor your blood glucose infrequently

How PlexusDx Supports a More Personalized Approach PlexusDx connects Canadian patients with compounded GLP-1 formulations prepared by licensed 503A pharmacies, offering a direct-to-provider pathway that can reduce wait times compared to some provincial approval processes